Losses continued for Sun Pharma’s research division, although they were narrower compared to the same quarter last year. Sanofi India’s results were also lower from last year.
Losses continued for Sun Pharma’s research division, although they were narrower compared to the same quarter last year. Sanofi India’s results were also lower from last year.